Antonio Montoto-Marqués

Prof. Dr. Antonio Montoto-Marqués

orcid

Research Focus & Metrics

Academic Career Length

26Years (2001-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 September 2013 in BioMed Research International
Verified
Journal Article
Open access
PDF file
RGRita Galeiras
Rita Galeiras
PSPedro Rascado Sedes
Pedro Rascado Sedes
MFMónica Mourelo Fariña
Mónica Mourelo Fariña
AMAntonio Montoto-Marqués
Antonio Montoto-Marqués
MVM. Elena Ferreiro Velasco
M. Elena Ferreiro Velasco
Spinal cord injuries (SCIs) often lead to impairment of the respiratory system and, consequently, restrictive respiratory changes. Paresis or paralysis of the respiratory muscles can lead to respiratory insufficiency, which is dependent on the level and completeness of the injury. Respiratory complications include hypoventilation, a reduction in surfactant production, mucus plugging, atelectasis, and pneumonia. Vital capacity (VC) is an indicator of overall pulmonary function; patients with severely impaired VC may require assisted ventilation. It is best to proceed with intubation under controlled circumstances rather than waiting until the condition becomes an emergency. Mechanical ventilation can adversely affect the structure and function of the diaphragm. Early tracheostomy following short orotracheal intubation is probably beneficial in selected patients. Weaning should start as soon as possible, and the best modality is progressive ventilator-free breathing (PVFB). Appropriate candidates can sometimes be freed from mechanical ventilation by electrical stimulation. Respiratory muscle training regimens may improve patients’ inspiratory function following a SCI.

19 October 2001 in Spinal Cord
Verified
Journal Article
Closed access
SBSebastián Salvador-De la Barrera
Sebastián Salvador-De la Barrera
ABA Barca-Buyo
A Barca-Buyo
AMAntonio Montoto-Marqués
Antonio Montoto-Marqués
MFMaE Ferreiro-Velasco
MaE Ferreiro-Velasco
MCM Cidoncha-Dans
M Cidoncha-Dans
ARA Rodriguez-Sotillo
A Rodriguez-Sotillo

10 August 2004 in Spinal Cord
Verified
Journal Article
Closed access
MFM E Ferreiro-Velasco
M E Ferreiro-Velasco
ABA Barca-Buyo
A Barca-Buyo
SBSebastián Salvador-De la Barrera
Sebastián Salvador-De la Barrera
AMAntonio Montoto-Marqués
Antonio Montoto-Marqués
XVX Miguéns Vázquez
X Miguéns Vázquez
ARA Rodríguez-Sotillo
A Rodríguez-Sotillo

14 February 2017 in Spinal Cord
Verified
Journal Article
Closed access
AMAntonio Montoto-Marqués
Antonio Montoto-Marqués
MFM E Ferreiro-Velasco
M E Ferreiro-Velasco
SBSebastián Salvador-De la Barrera
Sebastián Salvador-De la Barrera
VBVanesa Balboa-Barreiro
Vanesa Balboa-Barreiro
ARA Rodriguez-Sotillo
A Rodriguez-Sotillo
RMRosa Meijide-Faílde
Rosa Meijide-Faílde

Verified
Journal Article
Open access
PDF file
RMRodrigo Montoto Meijide
Rodrigo Montoto Meijide
RMRosa Meijide-Faílde
Rosa Meijide-Faílde
SILVIA MARÍA DÍAZ PRADOSILVIA MARÍA DÍAZ PRADO
SILVIA MARÍA DÍAZ PRADO
AMAntonio Montoto-Marqués
Antonio Montoto-Marqués
Recovery from a traumatic spinal cord injury (TSCI) is challenging due to the limited regenerative capacity of the central nervous system to restore cells, myelin, and neural connections. Cell therapy, particularly with mesenchymal stem cells (MSCs), holds significant promise for TSCI treatment. This systematic review aims to analyze the efficacy, safety, and therapeutic potential of MSC-based cell therapies in TSCI. A comprehensive search of PUBMED and COCHRANE databases until February 2023 was conducted, combining terms such as “spinal cord injury,” “stem cells,” “stem cell therapy,” “mesenchymal stem cells,” and “traumatic spinal cord injury”. Among the 53 studies initially identified, 22 (21 clinical trials and 1 case series) were included. Findings from these studies consistently demonstrate improvements in AIS (ASIA Impairment Scale) grades, sensory scores, and, to a lesser extent, motor scores. Meta-analyses further support these positive outcomes. MSC-based therapies have shown short- and medium-term safety, as indicated by the absence of significant adverse events within the studied timeframe. However, caution is required when drawing generalized recommendations due to the limited scientific evidence available. Further research is needed to elucidate the long-term safety and clinical implications of these advancements. Although significant progress has been made, particularly with MSC-based therapies, additional studies exploring other potential future therapies such as gene therapies, neurostimulation techniques, and tissue engineering approaches are essential for a comprehensive understanding of the evolving TSCI treatment landscape.

1 May 2017 in Medicina Intensiva (English Edition)
Verified
Journal Article
Closed access
RGRita Galeiras
Rita Galeiras
MVM.E. Ferreiro Velasco
M.E. Ferreiro Velasco
MFM. Mourelo Fariña
M. Mourelo Fariña
AMAntonio Montoto-Marqués
Antonio Montoto-Marqués
SBSebastián Salvador-De la Barrera
Sebastián Salvador-De la Barrera